Literature DB >> 18494686

Physiopathology of haemophilic arthropathy.

F P J G Lafeber1, P Miossec, L A Valentino.   

Abstract

Haemophilic arthropathy, which shares some clinical and biological injury characteristics with rheumatoid arthritis, is characterized by two main features: chronic proliferative synovitis and cartilage destruction. It is the consequence of repeated extravasation of blood into joint cavities, but its exact pathogenesis, particularly with regard to early changes in the joint, is still incompletely understood. This review presents recent findings obtained in experiments performed in vitro and using animal models, which have improved our knowledge of the pathogenesis of haemophilic arthropathy. These experimental studies show that haemophilic arthropathy is a multifactorial event in which the deposit of iron in the joints appears to exert a central role. First, iron may promote the apoptosis of chondrocytes by catalysing the formation of oxygen metabolites; this may explain the fact that intra-articular blood exerts a directly harmful effect on cartilage before, and independent of synovial changes. Secondly, iron may also act on the synovial membrane by favouring its proliferation through the induction of proto-oncogenes involved in cellular proliferation and stimulation of inflammatory cytokines as well as abrogation of apoptosis. These two processes, one degenerative and cartilage-mediated, the other inflammatory and synovium-mediated could occur in parallel or sequentially. Overall, it may be expected that these experimental results will yield new therapeutic strategies capable of effectively preventing the occurrence of this still serious and common complication in patients with severe haemophilia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18494686     DOI: 10.1111/j.1365-2516.2008.01732.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  29 in total

Review 1.  Wound healing in hemophilia B mice and low tissue factor mice.

Authors:  Dougald M Monroe; Nigel Mackman; Maureane Hoffman
Journal:  Thromb Res       Date:  2010-02-19       Impact factor: 3.944

2.  Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy.

Authors:  Charles L Campbell; Steven R Steinhubl; William C Hooper; Joseph Jozic; Susan S Smyth; Debra Bernstein; Christine De Staercke; George Syros; Brian H Negus; Thomas Stuckey; Gregg W Stone; Roxana Mehran; George Dangas
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

3.  IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia.

Authors:  N Narkbunnam; J Sun; G Hu; F-C Lin; T A Bateman; M Mihara; P E Monahan
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

4.  Trauma resulting in hemarthrosis and long medial collateral ligament desmitis of the tarsocrural joint in a horse.

Authors:  Nathalie Tokateloff; James Carmalt; Stephen Manning
Journal:  Can Vet J       Date:  2011-05       Impact factor: 1.008

5.  MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia.

Authors:  Wouter Foppen; Irene C van der Schaaf; Frederik J A Beek; Willem P T M Mali; Kathelijn Fischer
Journal:  Blood Adv       Date:  2020-01-14

6.  EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.

Authors:  Jhansi Magisetty; Usha R Pendurthi; Charles T Esmon; L Vijaya Mohan Rao
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

7.  Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats.

Authors:  Shannon M Zintner; Juliana C Small; Giulia Pavani; Lynn Dankner; Oscar A Marcos-Contreras; Phyllis A Gimotty; Mads Kjelgaard-Hansen; Bo Wiinberg; Paris Margaritis
Journal:  Blood Adv       Date:  2019-02-12

8.  Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A.

Authors:  Daniela Melchiorre; Silvia Linari; Mirko Manetti; Eloisa Romano; Francesco Sofi; Marco Matucci-Cerinic; Christian Carulli; Massimo Innocenti; Lidia Ibba-Manneschi; Giancarlo Castaman
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941

9.  Vascular remodeling underlies rebleeding in hemophilic arthropathy.

Authors:  Vikas Bhat; Merissa Olmer; Shweta Joshi; Donald L Durden; Thomas J Cramer; Richard Fw Barnes; Scott T Ball; Tudor H Hughes; Mauricio Silva; James V Luck; Randy E Moore; Laurent O Mosnier; Annette von Drygalski
Journal:  Am J Hematol       Date:  2015-10-08       Impact factor: 10.047

10.  Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.

Authors:  Marc Baud'huin; Laurence Duplomb; Stéphane Téletchéa; Céline Charrier; Mike Maillasson; Marc Fouassier; Dominique Heymann
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.